COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,387 Articles (22,816 medRxiv, 8,571 bioRxiv)

Most recent first Previous |  Page 1498: Articles 14971-14980  | Next

Signatures of mast cell activation are associated with severe COVID-19
Tan, J., Anderson, D., Rathore, A. P. S., O'Neill, A., Mantri, C. K., Saron, W. A. A., Lee, C., Chu, W. C., Kang, A., Foo, R., Kalimuddin, S., Low, J., Ho, L., Tambyah, P., Burke, T. W., Woods, C. W., Chan, K. R., Karhausen, J., St John, A. L.
10.1101/2021.05.31.21255594 — Posted: 2021-06-01 Discussion: Onsite | Offsite
Genomic epidemiology and associated clinical outcomes of a SARS-CoV-2 outbreak in a general adult hospital in Quebec
Pare, B., Rozendaal, M., Morin, S., Poujol, R., Mostefai, F., Grenier, J.-C., Kaufmann, L., Xing, H., Sanchez, M., Yechouron, A., Racette, R., Hussin, J., Wolf, G., Pavlov, I., Smith, M. A.
10.1101/2021.05.29.21257760 — Posted: 2021-06-01
COVID-19 Associated Mucormycosis: Scoping Review Protocol
Hussain, S., Baxi, H., Riad, A., Kulgarova, J., Licenik, R., Klugar, M.
10.1101/2021.05.30.21258068 — Posted: 2021-06-01
Stopping the misinformation: BNT16b2 COVID-19 vaccine has no negative effect on women's fertility
Safrai, M., Rottenstreich, A., Herzberg, S., Imbar, T., Reubinoff, B., Ben-Meir, A.
10.1101/2021.05.30.21258079 — Posted: 2021-06-01
Reliability of wastewater analysis for monitoring COVID-19 incidence revealed by a long-term follow-up study
Sanjuan, R., Domingo-Calap, P.
10.1101/2021.05.30.21257992 — Posted: 2021-06-01
Covid-19: Comparisons by Country and Implications for Future Pandemics
Mehl-Madrona, L. E., Bricaire, F., Cuyugan, A., Barac, J., Parvaiz, A., Jamil, A. B., Iqbal, S., Vally, R., Koliali, M., Sellier, M. K.
10.1101/2021.05.29.21258056 — Posted: 2021-06-01
Self-resetting Molecular Probes for Nucleic Acids Enabled by Fuel Dissipative Systems
Li, N., Liu, Y., Yin, Z., Liu, R., Zhang, L., Zhao, Y., Ma, L., Dai, X., Zhou, D., Su, X.
10.1101/2021.06.01.21257665 — Posted: 2021-06-01
Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity
Gross, R., Zanoni, M., Seidel, A., Conzelmann, C., Gilg, A., Krnavek, D., Erdemci-evin, S., Mayer, B., Hoffmann, M., Poehlmann, S., Beil, A., Kroschel, J., Jahrsdoerfer, B., Schrezenmeier, H., Kirchhoff, F., Muench, J., Mueller, J. A.
10.1101/2021.05.30.21257971 — Posted: 2021-06-01
Clarity Plus™ digital PCR: A novel platform for absolute quantification of SARS-CoV-2
Tan, S. Y. H., Kwek, M. S. Y., Low, H., Pang, Y. L. J.
10.1101/2021.05.30.21256718 — Posted: 2021-06-01
Acute kidney injury in hospitalized patients due to COVID-19
Fernandez, P., Saad, E. J., Douthat, A., Marucco, F. A., Heredia, M. C., Tarditi Barra, A., Rodriguez Bonazzi, S. T., Zlotogora, M., Correa Barovero, M. A., Villada, S., Maldonado, J. P., Caeiro, J. P., Albertini, R. A., De La Fuente, J. L., Douthat, W. G.
10.1101/2021.05.31.21257656 — Posted: 2021-06-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).